HCA Holdings Inc. buy Royal Bank of Canada
Start price
13.09.23
/
50%
€244.70
Target price
13.09.24
€293.45
Performance (%)
30.62%
Price
24.07.24
€317.30
Summary
This prediction is currently active. With a performance of 30.62% the BUY prediction by Royal_Bank_of_Canada is a big success. Dividends of €2.34 are taken into consideration when calculating the performance. This prediction currently runs until 13.09.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
HCA Holdings Inc. | 8.442% | 8.442% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread HCA Holdings Inc. diskutieren
HCA Healthcare, Inc. (NYSE: HCA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $315.00 price target on the stock.
Ratings data for HCA provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for HCA Holdings Inc.
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€314.80
24.07.24
24.07.24
€348.18
24.07.25
24.07.25
0.79%
24.07.24
24.07.24
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€290.50
29.04.24
29.04.24
€307.19
29.04.25
29.04.25
9.44%
24.07.24
24.07.24
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€282.20
31.01.24
31.01.24
€296.76
31.01.25
31.01.25
12.87%
24.07.24
24.07.24
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€213.30
25.10.23
25.10.23
€268.66
25.10.24
25.10.24
49.59%
24.07.24
24.07.24